'Companion diagnostics' presentation slideshows

Developing a Predictive Biomarker as a Companion Diagnostic for a Molecularly Targeted Cancer Drug

Developing a Predictive Biomarker as a Companion Diagnostic for a Molecularly Targeted Cancer Drug. Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute http://brb.nci.nih.gov. BRB Website http://brb.nci.nih.gov. Powerpoint presentations Reprints

755 views • 48 slides

The NICE Diagnostics Assessment Programme

350 views • 16 slides

The NICE Diagnostics Assessment Programme

169 views • 16 slides

Companion Diagnostics Market Share

Companion diagnostics development has majorly been focused at the treatment of the various types of cancers, their indications, and their indication subtypes. The following figure depicts the global companion diagnostics market according to the various types of cancer indications. The considered indications include breast cancer, colorectal cancer, leukemia, lung cancer, melanoma, stomach cancer, and other cancer types.

111 views • 10 slides

Molecular Diagnostics Market to grow at 8.1% CAGR from 2016 to 2023

Get more details @ http://bit.ly/2oUDIou Key industry players include Abbott Laboratories, Alere, Becton Dickinson, Bayer Healthcare, Bio-Rad Laboratories, Dako, bioMerieux, Cepheid, Hologic (Gen Probe), Danaher Corporation, Novartis (Grifols), Siemens Healthcare, Roche Diagnostics, Johnson & Johnson, Qiagen, and Sysmex Corporation.

105 views • 9 slides

Need for Higher Drug Efficacy to Drive Global Companion Diagnostics Market to US$5.6 Bn by 2019

In a recent market study from Transparency Market Research (TMR), the global companion diagnostics market is estimated to reach US$5.6 billion by 2019, increasing from US$1.8 billion in 2013. This growth amounts to a remarkable CAGR of 18.1% from 2013 to 2019.

248 views • 8 slides

Companion Diagnostics Market | Trends & forecast | 2018-2025

This report, from Stratview Research, studies the global clinical diagnostics market - companion diagnostics over the trend period of 2014 to 2017 and forecast period of 2018 to 2025.

85 views • 8 slides

Personalized Medicine Market

Companion Diagnostics to Foster the Transformational Trend Towards Personalized Medicine/n

616 views • 7 slides

In-vitro and Companion Diagnostics Industry

Global In-Vitro Diagnostics (IVD) and Companion Diagnostics (CDx) market set to boom in the next seven years

1.55k views • 7 slides

Precision Medicine Market forecast to witness growth of 10.5% from 2016 to 2023

Get more details @ http://bit.ly/2ekRPfD Key industry players contributing to global precision medicine market share include Pfizer, Roche, Covance, Novartis, Qiagen, Biocrates Life Sciences, Teva Pharmaceutical, Nanostring Technologies, Laboratory Corporation of America Holdings, Tepnel Pharma Services, Intomics, Ferrer InCode, Silicon Biosystems, Eagle Genomics, Medtronic, and Quest Diagnostics.

138 views • 7 slides

Molecular Diagnostics Market to reach $10bn by 2023

Get more details @ http://bit.ly/2oUDIou Key industry players include Abbott Laboratories, Alere, Becton Dickinson, Bayer Healthcare, Bio-Rad Laboratories, Dako, bioMerieux, Cepheid, Hologic (Gen Probe), Danaher Corporation, Novartis (Grifols), Siemens Healthcare, Roche Diagnostics, Johnson & Johnson, Qiagen, and Sysmex Corporation.

119 views • 6 slides

Global Companion Diagnostics Market

Global Companion Diagnostics Market was valued US$ 2.68 Bn in 2017 and is expected to reach US$ 10.76 Bn by 2026, at a CAGR of 18.98 % during a forecast period.

54 views • 5 slides

Theranostics involves combination of targeted diagnostic tests with targeted therapy. It is also known as companion diagnostics, integrated medicine, Dx/Rx partnering, and pharmacodiagnostics.

43 views • 4 slides

Global Aerogel Market (Raw material, Form, Application and Geography)

Global Companion Diagnostic Technologies Market (Indication and Geography). Global Aerogel Market (Raw material, Form, Application and Geography). No. of pages: 157 Published Date: Jun-2014.

43 views • 4 slides

Companion Diagnostics Market grow at a CAGR of 21.6% from 2016 to 2021

Global Companion Diagnostics Market published by Market Data Forecast, the global market is projected to reach USD 8.88 billion by 2021, at a CAGR of 21.6% from 2016 to 2021.

56 views • 3 slides

Companion Diagnostics Market Size, Share, Drivers & Trends Analysis to 2022

The report studies Companion Diagnostics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer.

52 views • 3 slides

Companion Diagnostics Market Size, Analysis and Forecast till 2026

Personalized medicine is the new segment in discussion among healthcare experts around the globe. Also, encouragement from the regulatory bodies such as the FDA and EMEA in erms of providing a defined structure for companion diagnostic development is driving research activities in personalized medicine. Diagnosis at molecular level for each individual is of prime importance to identify the target biomarker before deciding the therapy. Companion diagnostic is one such emerging field for target biomarker identification reducing clinical trial cost and time to market the product.

37 views • 3 slides

Companion diagnostics are molecular tests that provide essential information for the safety and effective use of the corresponding drug. These tests assist healthcare professionals to decide whether a specific treatment product benefits patient for curing disease, predict drug toxicities, off-target effects of treatment, and other adverse effects related to the drug.

35 views • 3 slides